BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27711074)

  • 1. P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy.
    Jia YL; Xu M; Dou CW; Liu ZK; Xue YM; Yao BW; Ding LL; Tu KS; Zheng X; Liu QG
    Cell Death Dis; 2016 Oct; 7(10):e2400. PubMed ID: 27711074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone acetyltransferase PCAF accelerates apoptosis by repressing a GLI1/BCL2/BAX axis in hepatocellular carcinoma.
    Gai X; Tu K; Li C; Lu Z; Roberts LR; Zheng X
    Cell Death Dis; 2015 Apr; 6(4):e1712. PubMed ID: 25855960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment.
    Zheng X; Xu M; Yao B; Wang C; Jia Y; Liu Q
    Cell Signal; 2016 Sep; 28(9):1314-1324. PubMed ID: 27297362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells.
    Gong L; Di C; Xia X; Wang J; Chen G; Shi J; Chen P; Xu H; Zhang W
    Int J Oncol; 2016 Dec; 49(6):2538-2548. PubMed ID: 27779641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
    Yang J; Pi C; Wang G
    Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone acetyltransferase PCAF up-regulated cell apoptosis in hepatocellular carcinoma via acetylating histone H4 and inactivating AKT signaling.
    Zheng X; Gai X; Ding F; Lu Z; Tu K; Yao Y; Liu Q
    Mol Cancer; 2013 Aug; 12(1):96. PubMed ID: 23981651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR.
    Li L; Liu JD; Gao GD; Zhang K; Song YW; Li HB
    Cancer Med; 2020 Sep; 9(17):6399-6410. PubMed ID: 32691991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP; Lee CH; Ying TH; Lin CL; Lin CL; Hsueh JT; Hsieh YH
    Oncotarget; 2015 Oct; 6(30):28851-66. PubMed ID: 26311737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway.
    Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG
    Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy.
    Chang Z; Shi G; Jin J; Guo H; Guo X; Luo F; Song Y; Jia X
    Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo.
    Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C
    J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mTOR inhibition in concurrence with ERK1/2 activation is involved in excessive autophagy induced by glycyrrhizin in hepatocellular carcinoma.
    Zhang X; Yang H; Yue S; He G; Qu S; Zhang Z; Ma B; Ding R; Peng W; Zhang H; Yang Z; Dou K; Tao K; Li X
    Cancer Med; 2017 Aug; 6(8):1941-1951. PubMed ID: 28675698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of PCAF in hepatocellular carcinoma and its clinical significance].
    Tuo H; Zheng X; Tu K; Zhou Z; Yao Y; Liu Q
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):297-300. PubMed ID: 23643089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma.
    Liu YL; Yang PM; Shun CT; Wu MS; Weng JR; Chen CC
    Autophagy; 2010 Nov; 6(8):1057-65. PubMed ID: 20962572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibited the progression of human hepatocellular carcinoma by inducing autophagy via regulating p53 and the phosphoinositide 3‑kinase/protein kinase B pathway.
    Zhang B; Yin X; Sui S
    Oncol Rep; 2018 Nov; 40(5):2758-2765. PubMed ID: 30132535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PCAF inhibits hepatocellular carcinoma metastasis by inhibition of epithelial-mesenchymal transition by targeting Gli-1.
    Li Q; Liu Z; Xu M; Xue Y; Yao B; Dou C; Jia Y; Wang Y; Tu K; Zheng X; Yao Y
    Cancer Lett; 2016 May; 375(1):190-198. PubMed ID: 26945969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Des-gamma-carboxy prothrombin antagonizes the effects of Sorafenib on human hepatocellular carcinoma through activation of the Raf/MEK/ERK and PI3K/Akt/mTOR signaling pathways.
    Cui SX; Shi WN; Song ZY; Wang SQ; Yu XF; Gao ZH; Qu XJ
    Oncotarget; 2016 Jun; 7(24):36767-36782. PubMed ID: 27167344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
    Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
    Molecules; 2019 May; 24(10):. PubMed ID: 31137633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.